Department of Radiation Oncology, University of Lubeck, Lubeck, Germany.
Cancer. 2012 Feb 15;118(4):1138-44. doi: 10.1002/cncr.26379. Epub 2011 Jul 14.
The current study was conducted to compare neurosurgical resection (NR) followed by whole-brain irradiation (WBI) (NR + WBI) with WBI followed by radiosurgery (WBI + RS) in patients with a single brain metastasis.
The outcome of 41 patients treated with WBI + RS was retrospectively compared with 111 patients who received NR ;+ WBI with respect to local control of the treated metastasis and survival. Eleven additional potential prognostic factors were investigated, including WBI schedule, patient age, patient gender, Karnofsky performance score (KPS), primary tumor type, extracerebral metastases, recursive partitioning analysis (RPA) class, interval between the first diagnosis of cancer to the treatment of brain metastasis, metastatic site, maximum diameter of the metastasis, and graded prognostic assessment (GPA) score.
The 1-year local control rates were 87% after WBI + RS and 56% after NR + WBI (P = .001). Using the Cox proportional hazards model, the treatment regimen remained significant (risk ratio [RR], 2.46; 95% confidence interval [95% CI], 1.29-5.17 [P = .005]). On the multivariate analysis, local control was also found to be associated with the maximum diameter of the metastasis. The 1-year survival rates were 61% after WBI + RS and 53% after NR + WBI (P = .16). Acute and late toxicities were similar in both groups. On the multivariate analysis, KPS, extracerebral metastases, RPA class, and the GPA score were found to be independent predictors of survival.
The use of WBI + RS resulted in significantly better local control of the treated metastasis than NR + WBI. Survival was not found to be significantly different in either group. Because WBI + RS is less invasive than NR + WBI, it appears to be preferable for many patients with a single brain metastasis. These results should be confirmed in a randomized trial.
本研究旨在比较单纯全脑放疗(WBI)后行立体定向放射外科治疗(WBI+RS)与先手术切除(NR)后行 WBI(NR+WBI)在单发脑转移瘤患者中的疗效。
回顾性比较 WBI+RS 治疗的 41 例患者与接受 NR+WBI 治疗的 111 例患者的局部肿瘤控制和生存情况。还研究了 11 个潜在的预后因素,包括 WBI 方案、患者年龄、性别、卡氏功能状态评分(KPS)、原发肿瘤类型、颅外转移、递归分割分析(RPA)分级、从首次诊断癌症到脑转移治疗的时间间隔、转移部位、转移灶最大直径和分级预后评估(GPA)评分。
WBI+RS 治疗后 1 年局部控制率为 87%,NR+WBI 治疗后为 56%(P=0.001)。采用 Cox 比例风险模型,治疗方案仍有显著差异(风险比[RR],2.46;95%置信区间[95%CI],1.29-5.17[P=0.005])。多因素分析显示,局部控制与转移灶最大直径也有关。WBI+RS 治疗后 1 年生存率为 61%,NR+WBI 治疗后为 53%(P=0.16)。两组的急性和迟发性毒性反应相似。多因素分析显示,KPS、颅外转移、RPA 分级和 GPA 评分是生存的独立预测因素。
与 NR+WBI 相比,WBI+RS 治疗单发脑转移瘤的局部控制效果显著更好。两组的生存率无显著差异。由于 WBI+RS 比 NR+WBI 侵袭性更小,因此对许多单发脑转移瘤患者来说似乎是更好的选择。这些结果需要在随机试验中得到证实。